Publication | Closed Access

Relationship between magnetic resonance imaging characteristics and plasmatic levels of MMP2 and MMP9 in patients with recurrent high-grade gliomas treated by Bevacizumab and Irinotecan

Neuro-oncologyPlasmatic LevelsMedicineRecurrent High-grade GliomasNeurologyHigh-grade GliomasCancer TreatmentOncologyGliomaDiagnostic NeuroradiologyTumor MicroenvironmentRadiology